BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19530214)

  • 1. The conundrum of migraine headaches in the presence of patent foramen ovale.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):130-1. PubMed ID: 19530214
    [No Abstract]   [Full Text] [Related]  

  • 2. Patent foramen ovale closure for migraine prevention: the subject is still open.
    Dodick DW
    JACC Cardiovasc Interv; 2010 Mar; 3(3):288-9. PubMed ID: 20298986
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent foramen ovale and migraine headaches: the saga continues.
    Tobis J
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):575-6. PubMed ID: 21351232
    [No Abstract]   [Full Text] [Related]  

  • 4. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure.
    Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
    Shi YJ; Lv J; Han XT; Luo GG
    BMC Cardiovasc Disord; 2017 Jul; 17(1):203. PubMed ID: 28747203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache.
    Khessali H; Mojadidi MK; Gevorgyan R; Levinson R; Tobis J
    JACC Cardiovasc Interv; 2012 Jun; 5(6):682-7. PubMed ID: 22721665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained long-term benefit of patent foramen ovale closure on migraine.
    Trabattoni D; Fabbiocchi F; Montorsi P; Galli S; Teruzzi G; Grancini L; Gatto P; Bartorelli AL
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):570-4. PubMed ID: 21351231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine and patent foramen ovale: the secret in the bubbles?
    Sacco S; Carolei A
    Headache; 2011 Jan; 51(1):165-7. PubMed ID: 20946435
    [No Abstract]   [Full Text] [Related]  

  • 9. Sharing a problem. We all should do more of it.
    Butman S
    Catheter Cardiovasc Interv; 2009 May; 73(6):832. PubMed ID: 19367651
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study.
    Chessa M; Colombo C; Butera G; Negura D; Piazza L; Varotto L; Bussadori C; Fesslova V; Meola G; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):401-5. PubMed ID: 19449455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device closure of patent foramen ovale--do similar devices achieve similar results?
    Kimmelstiel C
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):715. PubMed ID: 21433274
    [No Abstract]   [Full Text] [Related]  

  • 13. A meta-analysis of case-control studies of the association of migraine and patent foramen ovale.
    Takagi H; Umemoto T;
    J Cardiol; 2016 Jun; 67(6):493-503. PubMed ID: 26527111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine and patent foramen ovale: headache for patient and cardiologist.
    Blankenship JC
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):505-6. PubMed ID: 20333664
    [No Abstract]   [Full Text] [Related]  

  • 16. Percutaneous closure of patent foramen ovale and the risk of atrial fibrillation.
    Bhindi R
    Catheter Cardiovasc Interv; 2010 Feb; 75(2):301; author reply 302. PubMed ID: 20049956
    [No Abstract]   [Full Text] [Related]  

  • 17. Resident and fellow section.
    Levin M
    Headache; 2010 Apr; 50(4):687-91. PubMed ID: 20456155
    [No Abstract]   [Full Text] [Related]  

  • 18. Right-to-Left Shunt and the Clinical Features of Migraine with Aura: Earlier but Not More.
    Altamura C; Paolucci M; Costa CM; Brunelli N; Cascio Rizzo A; Cecchi G; Vernieri F
    Cerebrovasc Dis; 2019; 47(5-6):268-274. PubMed ID: 31357200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale: where are we in 2009?
    Sommer RJ
    Am J Ther; 2009; 16(6):562-72. PubMed ID: 19417592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale closure and subsequent atrial fibrillation.
    Tobis J
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):896. PubMed ID: 19902510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.